Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 2viv | VG2 | Urokinase-type plasminogen activator | 3.4.21.73 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 2viv | VG2 | Urokinase-type plasminogen activator | 3.4.21.73 | 1.000 | |
| 4fue | 7UP | Urokinase-type plasminogen activator | 3.4.21.73 | 0.536 | |
| 1sqt | UI3 | Urokinase-type plasminogen activator | 3.4.21.73 | 0.521 | |
| 1ejn | AGB | Urokinase-type plasminogen activator | 3.4.21.73 | 0.513 | |
| 3ig6 | 438 | Urokinase-type plasminogen activator | 3.4.21.73 | 0.504 | |
| 3k5c | 0BI | Beta-secretase 1 | 3.4.23.46 | 0.440 |